{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,11,13]],"date-time":"2023-11-13T01:17:52Z","timestamp":1699838272697},"reference-count":0,"publisher":"American Society for Microbiology","issue":"1","license":[{"start":{"date-parts":[[1972,1,1]],"date-time":"1972-01-01T00:00:00Z","timestamp":63072000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[1972,1]]},"abstract":"<jats:p>\n            The multiplication of\n            <jats:italic>Herpesvirus saimiri<\/jats:italic>\n            was inhibited in vitro by cytosine arabinoside, adenine arabinoside, and tilorone, but not by rifamycin SV.\n          <\/jats:p>","DOI":"10.1128\/aac.1.1.82","type":"journal-article","created":{"date-parts":[[2012,6,27]],"date-time":"2012-06-27T23:57:02Z","timestamp":1340841422000},"page":"82-83","update-policy":"http:\/\/dx.doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":6,"title":["Effect of Cytosine Arabinoside, Adenine Arabinoside, Tilorone, and Rifamycin SV on Multiplication of\n            <i>Herpesvirus saimiri<\/i>\n            In Vitro"],"prefix":"10.1128","volume":"1","author":[{"given":"R. H.","family":"Adamson","sequence":"first","affiliation":[{"name":"National Cancer Institute, Bethesda, Maryland 20014 and TRW\/Hazleton Laboratories, Vienna, Virginia 22180"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D. V.","family":"Ablashi","sequence":"additional","affiliation":[{"name":"National Cancer Institute, Bethesda, Maryland 20014 and TRW\/Hazleton Laboratories, Vienna, Virginia 22180"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G. R.","family":"Armstrong","sequence":"additional","affiliation":[{"name":"National Cancer Institute, Bethesda, Maryland 20014 and TRW\/Hazleton Laboratories, Vienna, Virginia 22180"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N. W.","family":"Ellmore","sequence":"additional","affiliation":[{"name":"National Cancer Institute, Bethesda, Maryland 20014 and TRW\/Hazleton Laboratories, Vienna, Virginia 22180"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"235","container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.1.1.82","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.1.1.82","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T23:04:40Z","timestamp":1645484680000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/AAC.1.1.82"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1972,1]]},"references-count":0,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1972,1]]}},"alternative-id":["10.1128\/AAC.1.1.82"],"URL":"https:\/\/doi.org\/10.1128\/aac.1.1.82","relation":{},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[1972,1]]},"assertion":[{"value":"1972-01-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}